FR2120073A1 - - Google Patents

Info

Publication number
FR2120073A1
FR2120073A1 FR7147019A FR7147019A FR2120073A1 FR 2120073 A1 FR2120073 A1 FR 2120073A1 FR 7147019 A FR7147019 A FR 7147019A FR 7147019 A FR7147019 A FR 7147019A FR 2120073 A1 FR2120073 A1 FR 2120073A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7147019A
Other languages
French (fr)
Other versions
FR2120073B1 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of FR2120073A1 publication Critical patent/FR2120073A1/fr
Application granted granted Critical
Publication of FR2120073B1 publication Critical patent/FR2120073B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces
    • Y10S435/896—Streptomyces fradiae
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/907—Streptosporangium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR7147019A 1970-12-28 1971-12-28 Expired FR2120073B1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2064092A DE2064092C2 (de) 1970-12-28 1970-12-28 Inhibitoren für Glykosidhydrolasen aus Actinomyceten

Publications (2)

Publication Number Publication Date
FR2120073A1 true FR2120073A1 (de) 1972-08-11
FR2120073B1 FR2120073B1 (de) 1975-12-26

Family

ID=5792372

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7147019A Expired FR2120073B1 (de) 1970-12-28 1971-12-28

Country Status (28)

Country Link
US (1) US3876766A (de)
JP (3) JPS5734996B1 (de)
KR (1) KR780000248B1 (de)
AR (1) AR193370A1 (de)
AT (1) AT330122B (de)
AU (1) AU461521B2 (de)
BE (1) BE777387A (de)
BG (3) BG25654A3 (de)
CA (1) CA979833A (de)
CH (1) CH594051A5 (de)
CS (1) CS167961B2 (de)
DD (1) DD99395A5 (de)
DE (1) DE2064092C2 (de)
DK (1) DK139533C (de)
ES (1) ES398358A1 (de)
FI (1) FI49774C (de)
FR (1) FR2120073B1 (de)
GB (1) GB1374751A (de)
IE (1) IE35920B1 (de)
IL (1) IL38441A (de)
LU (1) LU64319A1 (de)
NL (1) NL175199C (de)
NO (1) NO135873C (de)
PL (1) PL82900B1 (de)
RO (3) RO63064A (de)
SE (1) SE398357B (de)
SU (1) SU454750A3 (de)
ZA (1) ZA718677B (de)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2174239A1 (de) * 1972-03-01 1973-10-12 Bayer Ag
FR2174238A1 (de) * 1972-03-01 1973-10-12 Bayer Ag
FR2187330A1 (de) * 1972-03-01 1974-01-18 Bayer Ag
FR2378041A1 (fr) * 1977-01-19 1978-08-18 Bayer Ag Inhibiteur d'a-amylase, son procede de preparation a partir d'un streptomycete et son application en therapeutique
EP0003616A2 (de) * 1978-02-14 1979-08-22 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Neue Aminozucker-Derivate, ihre Herstellung und Amylase-hemmende Mittel
FR2416949A1 (fr) * 1978-02-10 1979-09-07 Taisho Pharmaceutical Co Ltd Procede de preparation d'inhibiteurs d'amylase, nouveaux produits ainsi obtenus et leurs utilisations pharmaceutiques, notamment pour combattre l'obesite et l'hyperglycemie

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4062950A (en) * 1973-09-22 1977-12-13 Bayer Aktiengesellschaft Amino sugar derivatives
US4010258A (en) * 1974-03-15 1977-03-01 Ajinomoto Co., Inc. Microbial amylase inhibitor and preparation thereof with the use of streptomyces diasticus var. amylostaticus
US4065557A (en) * 1974-03-21 1977-12-27 Bayer Aktiengesellschaft Amino sugars and their use in improving the meat:fat ratio in animals
US4065562A (en) * 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
FR2338707A1 (fr) * 1976-01-22 1977-08-19 Rhone Poulenc Ind Nouvel inhibiteur de glyco-hydrolases et sa preparation par culture d'un streptomyces
DE2658563A1 (de) * 1976-12-23 1978-06-29 Bayer Ag Inhibitoren fuer glykosid-hydrolasen aus bacillen
DE2719912C3 (de) * 1977-05-04 1979-12-06 Bayer Ag, 5090 Leverkusen Verfahren zur Isolierung von 0- |4,6-Dideoxy-4- [JJl S-O,4,6/5)-4,5,6-trihydroxy-3-hydroxymethyl-2cyclohexen-1-yl] -amino] - a -D-glucopyranosyl} -(I Pfeil nach rechts 4)-0- a D-glucopyranosyl-(l Pfeil nach rechts 4)-D-glucopyranose aus Kulturbrühen
JPS62160696A (ja) * 1986-01-07 1987-07-16 シャープ株式会社 電子式自動点滅器
EP0257418B1 (de) * 1986-08-13 1993-05-19 Hoechst Aktiengesellschaft Oxiran-Pseudooligosaccharide, Verfahren zu deren Herstellung, deren Verwendung und pharmazeutische Präparate
US5464828A (en) * 1988-03-02 1995-11-07 Chugai Pharmaceutical Co., Ltd. Aqueous suspension of sucralfate
DE19507214A1 (de) * 1995-03-02 1996-10-31 Bayer Ag Acarbose-Biosynthesegene aus Actinoplanes sp., Verfahren zu ihrer Isolierung sowie ihre Verwendung
EP0796915A3 (de) * 1996-03-22 1999-04-14 Bayer Ag Verfahren zur Herstellung sowie zur Verwendung von Acarviosyl-Transferase bei der Umwandlung von Acarbose-Homologen in Acarbose, zur Herstellung von Acarbose-Homologen
DE19637591A1 (de) * 1996-09-13 1998-03-19 Bayer Ag Osmokontrolliertes Fermentationsverfahren zur Herstellung von Acarbose
AU7457300A (en) 1999-10-28 2001-05-08 Chong Kun Dang Pharmaceutical Corp. A process for preparing acarbose with high purity
HRP20010792A2 (en) 2001-10-26 2003-04-30 Pliva D D Acarbose purification process
JP2015501641A (ja) 2011-12-08 2015-01-19 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ 関連するアクチノバクテリアの遺伝的形質転換のためのプラスミドとしての、アクチノプラネス属ｓｅ５０／１１０由来の新規な放線菌組込み接合エレメント
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
EP4045520A1 (de) 2019-10-16 2022-08-24 Bayer Aktiengesellschaft Verfahren zur verbesserten bildung von acarbose
MX2022011717A (es) 2020-03-23 2022-12-07 Bay State Milling Company Prueba rapida de pureza de semilla de trigo con alta amilosa.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3127315A (en) * 1964-03-31 Hypocholesterolemic agent m-

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2174239A1 (de) * 1972-03-01 1973-10-12 Bayer Ag
FR2174238A1 (de) * 1972-03-01 1973-10-12 Bayer Ag
FR2187330A1 (de) * 1972-03-01 1974-01-18 Bayer Ag
FR2378041A1 (fr) * 1977-01-19 1978-08-18 Bayer Ag Inhibiteur d'a-amylase, son procede de preparation a partir d'un streptomycete et son application en therapeutique
FR2416949A1 (fr) * 1978-02-10 1979-09-07 Taisho Pharmaceutical Co Ltd Procede de preparation d'inhibiteurs d'amylase, nouveaux produits ainsi obtenus et leurs utilisations pharmaceutiques, notamment pour combattre l'obesite et l'hyperglycemie
EP0003616A2 (de) * 1978-02-14 1979-08-22 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Neue Aminozucker-Derivate, ihre Herstellung und Amylase-hemmende Mittel
EP0003616A3 (en) * 1978-02-14 1979-09-05 F.Hoffmann-La Roche & Co. Aktiengesellschaft Amino sugar derivatives, their preparation and application as amylase inhibitors
US4273765A (en) * 1978-02-14 1981-06-16 Hoffmann-La Roche Inc. Amino sugar derivatives containing trehalose

Also Published As

Publication number Publication date
ES398358A1 (es) 1974-09-01
DK139533B (da) 1979-03-05
DD99395A5 (de) 1973-08-05
JPS6234396B2 (de) 1987-07-27
AU3721471A (en) 1973-09-27
IE35920L (en) 1972-06-28
RO63064A (fr) 1978-06-15
NO135873C (de) 1977-06-15
NO135873B (de) 1977-03-07
CH594051A5 (de) 1977-12-30
FR2120073B1 (de) 1975-12-26
JPS57150395A (en) 1982-09-17
LU64319A1 (de) 1972-06-13
JPS57150396A (en) 1982-09-17
NL175199C (nl) 1984-10-01
CA979833A (en) 1975-12-16
BG26002A4 (de) 1979-01-12
JPS6216638B2 (de) 1987-04-14
PL82900B1 (de) 1975-10-31
AR193370A1 (es) 1973-04-23
RO63065A (fr) 1979-02-15
IL38441A (en) 1974-10-22
DE2064092A1 (de) 1972-07-20
FI49774B (de) 1975-06-30
AU461521B2 (en) 1975-05-29
FI49774C (fi) 1975-10-10
KR780000248B1 (en) 1978-07-06
DE2064092C2 (de) 1983-06-01
IL38441A0 (en) 1972-02-29
SE398357B (sv) 1977-12-19
BG25654A3 (de) 1978-11-10
AT330122B (de) 1976-06-10
ATA1111571A (de) 1975-09-15
DK139533C (da) 1979-08-20
BG26003A4 (de) 1979-01-12
SU454750A3 (ru) 1974-12-25
NL175199B (nl) 1984-05-01
RO61400A (de) 1977-01-15
CS167961B2 (de) 1976-05-28
IE35920B1 (en) 1976-06-23
GB1374751A (en) 1974-11-20
BE777387A (fr) 1972-06-28
JPS5734996B1 (de) 1982-07-26
NL7117893A (de) 1972-06-30
US3876766A (en) 1975-04-08
ZA718677B (en) 1972-09-27

Similar Documents

Publication Publication Date Title
FR2120073B1 (de)
USB493463I5 (de)
AU1473870A (de)
AU2044470A (de)
AU2017870A (de)
AU2085370A (de)
AU2130570A (de)
AU2061170A (de)
AU1879170A (de)
AU1974970A (de)
AU1918570A (de)
AU1969370A (de)
AU1881070A (de)
AU2112570A (de)
AU1943370A (de)
AU1872870A (de)
AU2119370A (de)
AU2144270A (de)
AU2130770A (de)
AU1064870A (de)
AU2131570A (de)
BG16637A1 (de)
BG16967A1 (de)
BG18862A3 (de)
BG19182A3 (de)

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse